NL8302067A - 1,4-dihydropyridinederivaten, in optisch aktieve of in racemische vorm, werkwijzen voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten. - Google Patents

1,4-dihydropyridinederivaten, in optisch aktieve of in racemische vorm, werkwijzen voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten. Download PDF

Info

Publication number
NL8302067A
NL8302067A NL8302067A NL8302067A NL8302067A NL 8302067 A NL8302067 A NL 8302067A NL 8302067 A NL8302067 A NL 8302067A NL 8302067 A NL8302067 A NL 8302067A NL 8302067 A NL8302067 A NL 8302067A
Authority
NL
Netherlands
Prior art keywords
dihydro
benzoxadiazol
dimethyl
pyridinecarboxylic acid
ester
Prior art date
Application number
NL8302067A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8302067A publication Critical patent/NL8302067A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL8302067A 1982-06-15 1983-06-10 1,4-dihydropyridinederivaten, in optisch aktieve of in racemische vorm, werkwijzen voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten. NL8302067A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15
CH369282 1982-06-15
CH369382 1982-06-15

Publications (1)

Publication Number Publication Date
NL8302067A true NL8302067A (nl) 1984-01-02

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8302067A NL8302067A (nl) 1982-06-15 1983-06-10 1,4-dihydropyridinederivaten, in optisch aktieve of in racemische vorm, werkwijzen voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.

Country Status (19)

Country Link
AU (1) AU1575383A (fr)
BE (1) BE897000A (fr)
CA (1) CA1208639A (fr)
CH (1) CH660593A5 (fr)
DE (1) DE3320616A1 (fr)
DK (1) DK271183A (fr)
ES (2) ES8504179A1 (fr)
FI (1) FI832072L (fr)
FR (1) FR2528431B1 (fr)
GB (1) GB2122192B (fr)
HU (1) HU191853B (fr)
IT (1) IT1178353B (fr)
NL (1) NL8302067A (fr)
NZ (1) NZ204536A (fr)
PH (1) PH23436A (fr)
PT (1) PT76870B (fr)
SE (1) SE8303385L (fr)
WO (1) WO1984000033A1 (fr)
ZA (1) ZA834409B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0287828A1 (fr) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Produits intermédiaires et leur préparation
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
FI832072L (fi) 1983-12-16
DE3320616A1 (de) 1983-12-15
DK271183D0 (da) 1983-06-13
SE8303385L (sv) 1983-12-16
FR2528431A1 (fr) 1983-12-16
GB2122192A (en) 1984-01-11
CH660593A5 (de) 1987-05-15
NZ204536A (en) 1986-09-10
AU1575383A (en) 1983-12-22
ES8604578A1 (es) 1986-02-01
CA1208639A (fr) 1986-07-29
BE897000A (fr) 1983-12-09
PT76870B (en) 1986-02-27
ZA834409B (en) 1985-02-27
GB8316054D0 (en) 1983-07-20
IT1178353B (it) 1987-09-09
FI832072A0 (fi) 1983-06-08
ES523243A0 (es) 1985-04-01
DK271183A (da) 1983-12-16
WO1984000033A1 (fr) 1984-01-05
ES538157A0 (es) 1986-02-01
HU191853B (en) 1987-04-28
SE8303385D0 (sv) 1983-06-14
IT8348488A0 (it) 1983-06-13
ES8504179A1 (es) 1985-04-01
GB2122192B (en) 1985-12-18
PH23436A (en) 1989-08-07
PT76870A (en) 1983-07-01
FR2528431B1 (fr) 1986-01-10

Similar Documents

Publication Publication Date Title
CS418891A3 (en) Dihydropyridine derivatives, process of their preparation andpharmaceuticals containing said derivatives
EP1125924B1 (fr) Produit intermediaire pour la synthese d'amlodipine, et procede de preparation et d'utilisation correspondants
Guzman et al. Vilsmeier-Haack reaction with glutarimides. Synthesis of 2, 6-dichloro-1, 4-dihydropyridine-3, 5-dicarboxaldehydes
NL8302067A (nl) 1,4-dihydropyridinederivaten, in optisch aktieve of in racemische vorm, werkwijzen voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
KR930000167B1 (ko) 1,4-디하이드로피리딘 유도체의 제조방법
US20080070789A1 (en) Process for making amlodipine, derivatives thereof, and precursors therefor
JPS6360755B2 (fr)
CA1330994C (fr) Derives flavone
PL174647B1 (pl) Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy
WO2002053535A2 (fr) Procede de fabrication de l'amlodipine, derives de l'amlodipine et precurseurs associes
EP0257616B1 (fr) Dérivés de dihydropyridines et leurs compositions pharmaceutiques
CA1323876C (fr) Derives de dihydropyridine; compositions pharmaceutiques a base de ces derives
EP1407773A1 (fr) Procede pour la preparation des sels de s(-)amlodipine
CZ145489A3 (cs) Způsob přípravy dimethyl-1,4-dihydro-2,6-dimethyl-4-(2´-nitrofenyl)pyridin-3,5-dikarboxylátu
GB2117761A (en) 1 4-dihydropyridine derivatives their preparation and pharmaceutical composition
SK166495A3 (en) Pharmacologically effective enantiomers, preparation method threof, intermediate products of this method and use
EP0079740B1 (fr) Anthraniloyloxyalcanoates
RU2142942C1 (ru) Способ получения монобензолсульфоната 3-этил-5-метилового эфира 2-[(2-аминоэтокси)метил]-4-(2-хлорфенил)-1,4-дигидро-6-метил-3,5-пиридинди карбоновой кислоты
BE1014450A6 (nl) Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor.
AU2001100434A4 (en) Process for making amlodipine, derivatives thereof, and precursors therefore
FI94242B (fi) Menetelmä heterosyklisten johdannaisten valmistamiseksi
NL1018761C1 (nl) Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor.
CZ12783U1 (cs) Derivát amlodipinu
JPS6328064B2 (fr)
EP1577298A1 (fr) Procédé de dosage de pureté d'amlodipine

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed